167 related articles for article (PubMed ID: 23518657)
21. Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model.
Baines SD; O'Connor R; Saxton K; Freeman J; Wilcox MH
J Antimicrob Chemother; 2009 Mar; 63(3):520-5. PubMed ID: 19112083
[TBL] [Abstract][Full Text] [Related]
22. Characterization of Chicken IgY Specific to
Pizarro-Guajardo M; Díaz-González F; Álvarez-Lobos M; Paredes-Sabja D
Front Cell Infect Microbiol; 2017; 7():365. PubMed ID: 28856119
[No Abstract] [Full Text] [Related]
23. Inactivation of Clostridium difficile spore outgrowth by synergistic effects of nisin and lysozyme.
Chai C; Lee KS; Imm GS; Kim YS; Oh SW
Can J Microbiol; 2017 Jul; 63(7):638-643. PubMed ID: 28346844
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of linezolid for the treatment of Clostridium difficile infection caused by epidemic strains using an in vitro human gut model.
Baines SD; Noel AR; Huscroft GS; Todhunter SL; O'Connor R; Hobbs JK; Freeman J; Lovering AM; Wilcox MH
J Antimicrob Chemother; 2011 Jul; 66(7):1537-46. PubMed ID: 21504940
[TBL] [Abstract][Full Text] [Related]
25. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis.
Shoaei P; Shojaei H; Jalali M; Khorvash F; Hosseini SM; Ataei B; Vakili B; Ebrahimi F; Tavakoli H; Esfandiari Z; Weese JS
BMC Infect Dis; 2019 Apr; 19(1):361. PubMed ID: 31039738
[TBL] [Abstract][Full Text] [Related]
26. A prospective study of community-associated Clostridium difficile infections: the role of antibiotics and co-infections.
Taori SK; Wroe A; Hardie A; Gibb AP; Poxton IR
J Infect; 2014 Aug; 69(2):134-44. PubMed ID: 24780765
[TBL] [Abstract][Full Text] [Related]
27. Physical and chemical factors influencing the germination of Clostridium difficile spores.
Wheeldon LJ; Worthington T; Hilton AC; Elliott TS; Lambert PA
J Appl Microbiol; 2008 Dec; 105(6):2223-30. PubMed ID: 19120667
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Clostridium difficile isolates from individuals with recurrent and single episode of infection.
Richardson C; Kim P; Lee C; Bersenas A; Weese JS
Anaerobe; 2015 Jun; 33():105-8. PubMed ID: 25769665
[TBL] [Abstract][Full Text] [Related]
29. Updates on Clostridium difficile spore biology.
Gil F; Lagos-Moraga S; Calderón-Romero P; Pizarro-Guajardo M; Paredes-Sabja D
Anaerobe; 2017 Jun; 45():3-9. PubMed ID: 28254263
[TBL] [Abstract][Full Text] [Related]
30. Spores of Clostridium difficile clinical isolates display a diverse germination response to bile salts.
Heeg D; Burns DA; Cartman ST; Minton NP
PLoS One; 2012; 7(2):e32381. PubMed ID: 22384234
[TBL] [Abstract][Full Text] [Related]
31.
Zhu D; Sorg JA; Sun X
Front Cell Infect Microbiol; 2018; 8():29. PubMed ID: 29473021
[No Abstract] [Full Text] [Related]
32. Terbium chloride influences Clostridium difficile spore germination.
Shrestha R; Sorg JA
Anaerobe; 2019 Aug; 58():80-88. PubMed ID: 30926439
[TBL] [Abstract][Full Text] [Related]
33. Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection.
Suárez-Bode L; Barrón R; Pérez JL; Mena A
Anaerobe; 2019 Feb; 55():124-129. PubMed ID: 30550807
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes.
Falcone M; Tiseo G; Iraci F; Raponi G; Goldoni P; Delle Rose D; Santino I; Carfagna P; Murri R; Fantoni M; Fontana C; Sanguinetti M; Farcomeni A; Antonelli G; Aceti A; Mastroianni C; Andreoni M; Cauda R; Petrosillo N; Venditti M
Clin Microbiol Infect; 2019 Apr; 25(4):474-480. PubMed ID: 29964230
[TBL] [Abstract][Full Text] [Related]
35. Germination response of spores of the pathogenic bacterium Clostridium perfringens and Clostridium difficile to cultured human epithelial cells.
Paredes-Sabja D; Sarker MR
Anaerobe; 2011 Apr; 17(2):78-84. PubMed ID: 21315167
[TBL] [Abstract][Full Text] [Related]
36. Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
Nyc O; Tejkalova R; Kriz Z; Ruzicka F; Kubicek L; Matejkova J; Kuijper E; Krutova M
Microb Drug Resist; 2017 Jul; 23(5):609-615. PubMed ID: 27860531
[TBL] [Abstract][Full Text] [Related]
37. Fate of ingested Clostridium difficile spores in mice.
Howerton A; Patra M; Abel-Santos E
PLoS One; 2013; 8(8):e72620. PubMed ID: 24023628
[TBL] [Abstract][Full Text] [Related]
38. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
[TBL] [Abstract][Full Text] [Related]
39. Carvacrol reduces Clostridium difficile sporulation and spore outgrowth in vitro.
Mooyottu S; Flock G; Venkitanarayanan K
J Med Microbiol; 2017 Aug; 66(8):1229-1234. PubMed ID: 28786786
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of Clostridium difficile infection in hospitalized adults and the first isolation of C. difficile PCR ribotype 027 in central China.
Zhou Y; Mao L; Yu J; Lin Q; Luo Y; Zhu X; Sun Z
BMC Infect Dis; 2019 Mar; 19(1):232. PubMed ID: 30845918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
